NCT00731328View on ClinicalTrials.gov

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
LeukemiaMyelodysplastic SyndromesNonmalignant NeoplasmParoxysmal Nocturnal Hemoglobinuria
Interventions
PROCEDURE

nonmyeloablative allogeneic hematopoietic stem cell transplantation

infusion of mobilized donor hematopoietic progenitor cells

Trial Locations (1)

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER